IBS Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014575354
Market Monitor Global
Oct-2021
Life Sciences
112 Pages

This report contains market size and forecasts of IBS Treatment in Global, including the following market information:
Global IBS Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global IBS Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IBS Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global IBS Treatment Market Segment Percentages, By Type, 2020 (%)
IBS-D
IBS-C
IBS-M

China IBS Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China IBS Treatment Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Research Laboratories

Global IBS Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global IBS Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total IBS Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total IBS Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Allergan (Ireland)
Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals (U.S.)
Astellas Pharma (Japan)
Bausch Health
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals (U.S.)
Ardelyx (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA (Italy)
RedHill Biopharma (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis (Switzerland)
Takeda Pharmaceutical Company (Japan)
Synthetic Biologics (U.S.)
Protagonist Therapeutics (U.S.)
Pfizer (U.S.)
Lexicon Pharmaceuticals (U.S.)
Innovate Biopharmaceuticals (U.S.)

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 IBS Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IBS Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IBS Treatment Overall Market Size
2.1 Global IBS Treatment Market Size: 2021 VS 2027
2.2 Global IBS Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top IBS Treatment Players in Global Market
3.2 Top Global IBS Treatment Companies Ranked by Revenue
3.3 Global IBS Treatment Revenue by Companies
3.4 Top 3 and Top 5 IBS Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies IBS Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 IBS Treatment Players in Global Market
3.6.1 List of Global Tier 1 IBS Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 IBS Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global IBS Treatment Market Size Markets, 2021 & 2027
4.1.2 IBS-D
4.1.3 IBS-C
4.1.4 IBS-M
4.2 By Type - Global IBS Treatment Revenue & Forecasts
4.2.1 By Type - Global IBS Treatment Revenue, 2016-2021
4.2.2 By Type - Global IBS Treatment Revenue, 2022-2027
4.2.3 By Type - Global IBS Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global IBS Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Laboratories
5.2 By Application - Global IBS Treatment Revenue & Forecasts
5.2.1 By Application - Global IBS Treatment Revenue, 2016-2021
5.2.2 By Application - Global IBS Treatment Revenue, 2022-2027
5.2.3 By Application - Global IBS Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global IBS Treatment Market Size, 2021 & 2027
6.2 By Region - Global IBS Treatment Revenue & Forecasts
6.2.1 By Region - Global IBS Treatment Revenue, 2016-2021
6.2.2 By Region - Global IBS Treatment Revenue, 2022-2027
6.2.3 By Region - Global IBS Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America IBS Treatment Revenue, 2016-2027
6.3.2 US IBS Treatment Market Size, 2016-2027
6.3.3 Canada IBS Treatment Market Size, 2016-2027
6.3.4 Mexico IBS Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe IBS Treatment Revenue, 2016-2027
6.4.2 Germany IBS Treatment Market Size, 2016-2027
6.4.3 France IBS Treatment Market Size, 2016-2027
6.4.4 U.K. IBS Treatment Market Size, 2016-2027
6.4.5 Italy IBS Treatment Market Size, 2016-2027
6.4.6 Russia IBS Treatment Market Size, 2016-2027
6.4.7 Nordic Countries IBS Treatment Market Size, 2016-2027
6.4.8 Benelux IBS Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia IBS Treatment Revenue, 2016-2027
6.5.2 China IBS Treatment Market Size, 2016-2027
6.5.3 Japan IBS Treatment Market Size, 2016-2027
6.5.4 South Korea IBS Treatment Market Size, 2016-2027
6.5.5 Southeast Asia IBS Treatment Market Size, 2016-2027
6.5.6 India IBS Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America IBS Treatment Revenue, 2016-2027
6.6.2 Brazil IBS Treatment Market Size, 2016-2027
6.6.3 Argentina IBS Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa IBS Treatment Revenue, 2016-2027
6.7.2 Turkey IBS Treatment Market Size, 2016-2027
6.7.3 Israel IBS Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia IBS Treatment Market Size, 2016-2027
6.7.5 UAE IBS Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Allergan (Ireland)
7.1.1 Allergan (Ireland) Corporate Summary
7.1.2 Allergan (Ireland) Business Overview
7.1.3 Allergan (Ireland) IBS Treatment Major Product Offerings
7.1.4 Allergan (Ireland) IBS Treatment Revenue in Global (2016-2021)
7.1.5 Allergan (Ireland) Key News
7.2 Sucampo Pharmaceuticals (U.S.)
7.2.1 Sucampo Pharmaceuticals (U.S.) Corporate Summary
7.2.2 Sucampo Pharmaceuticals (U.S.) Business Overview
7.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Major Product Offerings
7.2.4 Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.2.5 Sucampo Pharmaceuticals (U.S.) Key News
7.3 Ironwood Pharmaceuticals (U.S.)
7.3.1 Ironwood Pharmaceuticals (U.S.) Corporate Summary
7.3.2 Ironwood Pharmaceuticals (U.S.) Business Overview
7.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Major Product Offerings
7.3.4 Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.3.5 Ironwood Pharmaceuticals (U.S.) Key News
7.4 Astellas Pharma (Japan)
7.4.1 Astellas Pharma (Japan) Corporate Summary
7.4.2 Astellas Pharma (Japan) Business Overview
7.4.3 Astellas Pharma (Japan) IBS Treatment Major Product Offerings
7.4.4 Astellas Pharma (Japan) IBS Treatment Revenue in Global (2016-2021)
7.4.5 Astellas Pharma (Japan) Key News
7.5 Bausch Health
7.5.1 Bausch Health Corporate Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health IBS Treatment Major Product Offerings
7.5.4 Bausch Health IBS Treatment Revenue in Global (2016-2021)
7.5.5 Bausch Health Key News
7.6 Abbott Laboratories (U.S.)
7.6.1 Abbott Laboratories (U.S.) Corporate Summary
7.6.2 Abbott Laboratories (U.S.) Business Overview
7.6.3 Abbott Laboratories (U.S.) IBS Treatment Major Product Offerings
7.6.4 Abbott Laboratories (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.6.5 Abbott Laboratories (U.S.) Key News
7.7 Synergy Pharmaceuticals (U.S.)
7.7.1 Synergy Pharmaceuticals (U.S.) Corporate Summary
7.7.2 Synergy Pharmaceuticals (U.S.) Business Overview
7.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Major Product Offerings
7.4.4 Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.7.5 Synergy Pharmaceuticals (U.S.) Key News
7.8 Ardelyx (U.S.)
7.8.1 Ardelyx (U.S.) Corporate Summary
7.8.2 Ardelyx (U.S.) Business Overview
7.8.3 Ardelyx (U.S.) IBS Treatment Major Product Offerings
7.8.4 Ardelyx (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.8.5 Ardelyx (U.S.) Key News
7.9 Nestle (Switzerland)
7.9.1 Nestle (Switzerland) Corporate Summary
7.9.2 Nestle (Switzerland) Business Overview
7.9.3 Nestle (Switzerland) IBS Treatment Major Product Offerings
7.9.4 Nestle (Switzerland) IBS Treatment Revenue in Global (2016-2021)
7.9.5 Nestle (Switzerland) Key News
7.10 Sebela Pharmaceuticals (Ireland)
7.10.1 Sebela Pharmaceuticals (Ireland) Corporate Summary
7.10.2 Sebela Pharmaceuticals (Ireland) Business Overview
7.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Major Product Offerings
7.10.4 Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue in Global (2016-2021)
7.10.5 Sebela Pharmaceuticals (Ireland) Key News
7.11 Probi (Sweden)
7.11.1 Probi (Sweden) Corporate Summary
7.11.2 Probi (Sweden) Business Overview
7.11.3 Probi (Sweden) IBS Treatment Major Product Offerings
7.11.4 Probi (Sweden) IBS Treatment Revenue in Global (2016-2021)
7.11.5 Probi (Sweden) Key News
7.12 Alfasigma USA (Italy)
7.12.1 Alfasigma USA (Italy) Corporate Summary
7.12.2 Alfasigma USA (Italy) Business Overview
7.12.3 Alfasigma USA (Italy) IBS Treatment Major Product Offerings
7.12.4 Alfasigma USA (Italy) IBS Treatment Revenue in Global (2016-2021)
7.12.5 Alfasigma USA (Italy) Key News
7.13 RedHill Biopharma (Israel)
7.13.1 RedHill Biopharma (Israel) Corporate Summary
7.13.2 RedHill Biopharma (Israel) Business Overview
7.13.3 RedHill Biopharma (Israel) IBS Treatment Major Product Offerings
7.13.4 RedHill Biopharma (Israel) IBS Treatment Revenue in Global (2016-2021)
7.13.5 RedHill Biopharma (Israel) Key News
7.14 AstraZeneca (U.K)
7.14.1 AstraZeneca (U.K) Corporate Summary
7.14.2 AstraZeneca (U.K) Business Overview
7.14.3 AstraZeneca (U.K) IBS Treatment Major Product Offerings
7.14.4 AstraZeneca (U.K) IBS Treatment Revenue in Global (2016-2021)
7.14.5 AstraZeneca (U.K) Key News
7.15 Ipsen (France)
7.15.1 Ipsen (France) Corporate Summary
7.15.2 Ipsen (France) Business Overview
7.15.3 Ipsen (France) IBS Treatment Major Product Offerings
7.15.4 Ipsen (France) IBS Treatment Revenue in Global (2016-2021)
7.15.5 Ipsen (France) Key News
7.16 Novartis (Switzerland)
7.16.1 Novartis (Switzerland) Corporate Summary
7.16.2 Novartis (Switzerland) Business Overview
7.16.3 Novartis (Switzerland) IBS Treatment Major Product Offerings
7.16.4 Novartis (Switzerland) IBS Treatment Revenue in Global (2016-2021)
7.16.5 Novartis (Switzerland) Key News
7.17 Takeda Pharmaceutical Company (Japan)
7.17.1 Takeda Pharmaceutical Company (Japan) Corporate Summary
7.17.2 Takeda Pharmaceutical Company (Japan) Business Overview
7.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Major Product Offerings
7.17.4 Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue in Global (2016-2021)
7.17.5 Takeda Pharmaceutical Company (Japan) Key News
7.18 Synthetic Biologics (U.S.)
7.18.1 Synthetic Biologics (U.S.) Corporate Summary
7.18.2 Synthetic Biologics (U.S.) Business Overview
7.18.3 Synthetic Biologics (U.S.) IBS Treatment Major Product Offerings
7.18.4 Synthetic Biologics (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.18.5 Synthetic Biologics (U.S.) Key News
7.19 Protagonist Therapeutics (U.S.)
7.19.1 Protagonist Therapeutics (U.S.) Corporate Summary
7.19.2 Protagonist Therapeutics (U.S.) Business Overview
7.19.3 Protagonist Therapeutics (U.S.) IBS Treatment Major Product Offerings
7.19.4 Protagonist Therapeutics (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.19.5 Protagonist Therapeutics (U.S.) Key News
7.20 Pfizer (U.S.)
7.20.1 Pfizer (U.S.) Corporate Summary
7.20.2 Pfizer (U.S.) Business Overview
7.20.3 Pfizer (U.S.) IBS Treatment Major Product Offerings
7.20.4 Pfizer (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.20.5 Pfizer (U.S.) Key News
7.21 Lexicon Pharmaceuticals (U.S.)
7.21.1 Lexicon Pharmaceuticals (U.S.) Corporate Summary
7.21.2 Lexicon Pharmaceuticals (U.S.) Business Overview
7.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Major Product Offerings
7.21.4 Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.21.5 Lexicon Pharmaceuticals (U.S.) Key News
7.22 Innovate Biopharmaceuticals (U.S.)
7.22.1 Innovate Biopharmaceuticals (U.S.) Corporate Summary
7.22.2 Innovate Biopharmaceuticals (U.S.) Business Overview
7.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Major Product Offerings
7.22.4 Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue in Global (2016-2021)
7.22.5 Innovate Biopharmaceuticals (U.S.) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. IBS Treatment Market Opportunities & Trends in Global Market
Table 2. IBS Treatment Market Drivers in Global Market
Table 3. IBS Treatment Market Restraints in Global Market
Table 4. Key Players of IBS Treatment in Global Market
Table 5. Top IBS Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global IBS Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global IBS Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies IBS Treatment Product Type
Table 9. List of Global Tier 1 IBS Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IBS Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE